Rob White, Chief Executive Officer, Cerebral Palsy Alliance, invites you to an exclusive
opportunity to hear the latest updates from world leaders in cerebral palsy research.
Registration for this event is now closed.
Australia’s first clinical trial of stem cell infusion from cord blood as a possible treatment for cerebral palsy (CP) is commencing in Melbourne. The safety trial, led by the Murdoch Childrens Research Institute (MCRI), will recruit patients nationally and take place at The Royal Children’s Hospital. Expected to take two years, the study is being funded by the Cerebral Palsy Alliance Research Foundation and Cell Care, Australia’s largest private cord blood bank. It is the first step in a promising process that eventually aims to find out whether cord blood infusion is both safe and efficacious for children with the condition.
A monthly donation will help ensure we can continue to fund the best research in Australia and internationally for a future without cerebral palsy.